NCT00061945 2022-05-03Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Completed302 enrolled 11 charts
NCT00109837 2015-03-25S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaSWOG Cancer Research NetworkPhase 2 Completed79 enrolled 6 charts